Complement Factor H Polymorphism and Age-Related Macular Degeneration
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration (AMD) is a common, late-onset, and complex trait with multiple risk factors. Concentrating on a region harboring a locus for AMD on 1q25-31, the ARMD1 locus, we tested single-nucleotide polymorphisms for association with AMD in two independent case-control populations. Significant association ( P = 4.95 × 10 -10 ) was identified within the regulation of complement activation locus and was centered over a tyrosine-402 → histidine-402 protein polymorphism in the gene encoding complement factor H. Possession of at least one histidine at amino acid position 402 increased the risk of AMD 2.7-fold and may account for 50% of the attributable risk of AMD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A major AMD-associated SNP is the Y402H (tyrosine to histidine substitution at amino acid 402) variant of complement factor H (CFH) (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Edwards et al., 2005
In the citing paper
“These SNPs have been reported to be major genetic factors for developing AMD in Caucasians (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005; Tuo et al., 2006).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Edwards et al., 2005
In the citing paper
“Complement activation playing a major role in AMD pathogenesis is yet another source of inflammation [107-110].”
From Risk mitigation of immunogenicity: a key to personalized retinal gene therapy (2021) · cites this paper as [108]
In the citing paper
“Polymorphisms in human complement regulatory factor H (CFH) predispose individuals to AMD [35, 46, 59]”
From Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain (2022) · cites this paper as [35]
In the citing paper
“Genes in the complement pathway4–11 and a region of chromosome 10 12,13 have now been implicated as the major genetic contributors to disease.”
From Seven new loci associated with age-related macular degeneration (2013) · cites this paper as [4]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Haploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,525
Prevalence of Age-Related Macular Degeneration in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.564 · Cited by 2,736
Score Tests for Association between Traits and Haplotypes when Linkage Phase Is Ambiguous
Schaid, D. J., Rowland, C. M., Tines, D. E., Jacobson, R. M., & Poland, G. A. (2002) · The American Journal of Human Genetics · doi:10.1086/338688 · Cited by 1,783
The Five-year Incidence and Progression of Age-related Maculopathy
Klein, R., Klein, B. E. K., Jensen, S. C., & Meuer, S. M. (1997) · Ophthalmology · doi:10.1016/s0161-6420(97)30368-6 · Cited by 1,135
Mullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937
The epidemiology of age-related macular degeneration
Klein, R., Peto, T., Bird, A., & Vannewkirk, M. R. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2003.11.069 · Cited by 932
Johnson, L. V., Leitner, W. P., Staples, M. K., & Anderson, D. H. (2001) · Experimental Eye Research · doi:10.1006/exer.2001.1094 · Cited by 621
Molecular Biology and Chemistry of the Alternative Pathway of Complement
Müller-Eberhard, H. J., & Schreiber, R. D. (1980) · Advances in Immunology · doi:10.1016/s0065-2776(08)60042-5 · Cited by 408
Seddon, J. M. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.6.785 · Cited by 398
Keenan, T. D., & Chew, E. Y. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.2210 · Cited by 377
Research works printed but not linked: 1
- M. H. Wener, P. R. Daum, G. M. McQuillan, J. Rheumatol.27, 2351 (2000).
Cited by
Items 701–800 of 1,021
Chi, Z.-L., Yoshida, T., Lambris, J. D., & Iwata, T. (2010) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-5635-4_9 · Cited by 64
“Recently, a polymorphism of complement factor H (CFH) gene (Y402H) was shown to be associated with an increased risk for AMD (Klein et al. 2005; Edwards et al. 2005; Haines et al. 2005; Hageman et al. 2005).”
Age-related macular degeneration: a perspective on genetic studies
Patel, N., Adewoyin, T., & Chong, V. N. (2007) · Eye · doi:10.1038/sj.eye.6702844 · Cited by 72
Complement Factor H Increases Risk for Atrophic Age-Related Macular Degeneration
Postel, E. A., AGARWAL, A., CALDWELL, J., Gallins, P. J., Toth, C. A., SCHMIDT, S., Scott, W. K., HAUSER, M., Haines, J. L., & Pericak‐Vance, M. A. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.02.049 · Cited by 68
Future Use of Genomics in Coronary Artery Disease
Damani, S. B., & Topol, E. J. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.062 · Cited by 76
Chae, J., Jang, H., Son, C., Park, C., Choi, H., Jin, S., Lee, H., Lee, H., Ryu, J., Kim, N., et al. (2021) · GeroScience · doi:10.1007/s11357-021-00457-4 · Cited by 67
Silveira, A. C., Morrison, M. A., Ji, F., Xu, H., Reinecke, J. B., Adams, S. M., Arneberg, T. M., Janssian, M., Lee, J.-E., Yuan, Y., et al. (2010) · Vision Research · doi:10.1016/j.visres.2009.09.016 · Cited by 63
“…genes age-related maculopathy susceptibility 2 and HtrA serine peptidase 1 (ARMS2 and HTRA1) (10q26) (DeAngelis et al., 2008; Dewan et al., 2006; Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Jakobsdottir et al., 2005; Kanda et al., 2007; Klein et al., 2005; Li et al., 2006;…”
Self-citationShuler, R. K. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.1.63 · Cited by 64
Tuo, J., Ross, R. J., Reed, G. F., Yan, Q., Wang, J. J., Bojanowski, C. M., Chew, E. Y., Feng, X., Olsen, T. W., Ferris, F. L., et al. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.05.021 · Cited by 63
Maurya, M., Bora, K., Blomfield, A. K., Pavlovich, M. C., Huang, S., Liu, C.-H., & Chen, J. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.369098 · Cited by 63
“For instance, in neovascular AMD patients, AREDS supplements resulted in a lower risk of AMD progression to an advanced stage in high-risk ARMS2 (TT) and non-risk CFH allele (TT) group, but not in CFH high-risk allele (CC) group, yet similar results were not seen in GA (Seddon et al., 2016; Vavvas et al., 2018).”
InfluentialA Novel Role of Complement in Retinal Degeneration
Yu, M., Zou, W., Peachey, N. S., McIntyre, T. M., & Liu, J. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-10069 · Cited by 61
Network analysis of human glaucomatous optic nerve head astrocytes
Nikolskaya, T., Nikolsky, Y., Serebryiskaya, T., Zvereva, S. D., Sviridov, E., Dezső, Z., Rahkmatulin, E., Brennan, R., Yankovsky, N. K., Bhattacharya, S. K., et al. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-24 · Cited by 72
“Complement activation has been implicated in CNS injury and inflammation, brain ischemia, Alzheimer's and Parkinson's diseases, and more recently, in agerelated macular degeneration (AMD) [26,73,74].”
BackgroundKanda, A., Stambolian, D. E., Chen, W., Curcio, C. A., Abecasis, G. R., & Swaroop, A. (2010) · PubMed Central · Cited by 75
Fuse, N., Miyazawa, A., Mengkegale, M. G., Yoshida, M., Wakusawa, R., Abe, T., & Tamai, M. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.07.030 · Cited by 63
Baldassano, R. N., Bradfield, J. P., Monos, D. S., Kim, C. E., Glessner, J., Casalunovo, T., Frackelton, E. C., Otieno, F. G., Kanterakis, S., Shaner, J. L., et al. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.04.024 · Cited by 63
Mori, K., Horie‐Inoue, K., Kohda, M., Kawasaki, I., Gehlbach, P. L., Awata, T., Yoneya, S., Okazaki, Y., & Inoue, S. (2007) · Journal of Human Genetics · doi:10.1007/s10038-007-0162-1 · Cited by 69
“In the CFH gene, the Y402H variant and other intron variants have been proposed as potentially causative factors in more than ten different Caucasian populations of European descendent (Zareparsi et al. 2005; Klein et al. 2005; Haines et al. 2005; Edwards et al. 2005; Hageman et al. 2005; Li et al. 2006; Maller et al.…”
BackgroundRohrer, B., Coughlin, B., Kunchithapautham, K., Long, Q., Tomlinson, S., Takahashi, K., & Holers, V. M. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2010.12.016 · Cited by 62
“The strongest argument in support of the involvement of the AP pathway comes from both animal and human data (e.g., (Bora et al., 2006; Rohrer et al., 2009 and Edwards et al., 2005; Gold et al., 2006; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005)).”
BackgroundBojanowski, C. M., Shen, D., Chew, E. Y., Ning, B., Csaky, K. G., Green, W. R., Chan, C., & Tuo, J. (2006) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20233 · Cited by 62
Complement factor H–deficient mice develop spontaneous hepatic tumors
Laskowski, J., Renner, B., Pickering, M. C., Serkova, N. J., Smith-Jones, P. M., Clambey, E. T., Nemenoff, R. A., & Thurman, J. M. (2020) · Journal of Clinical Investigation · doi:10.1172/jci135105 · Cited by 75
“Mutations in CFH binding regions are primarily associated with diseases of the kidneys and eyes (8, 17), possibly because these organs have specialized basement membranes that are highly exposed to plasma proteins.”
BackgroundSeddon, J. M., Reynolds, R. C., & ROSNER, B. A. (2010) · PubMed Central · Cited by 75
Kopplin, L. J., Igo, R. P., Wang, Y., Sivakumaran, T. A., Hagstrom, S. A., Peachey, N. S., Francis, P. J., Klein, M. L., SanGiovanni, J. P., Chew, E. Y., et al. (2010) · Genes and Immunity · doi:10.1038/gene.2010.39 · Cited by 71
“…evidence at the complement factor H ( CFH ), complement factor B ( BF ) / complement component 2 ( C2 ) and complement component 3 ( C3 ) genes.7–14 Variants at the age-related maculopathy susceptibility 2 ( ARMS2 ) locus have been shown to increase AMD risk15–20 as have variants in the…”
Machalińska, A., Dziedziejko, V., Mozolewska-Piotrowska, K., Karczewicz, D., Wiszniewska, B., & Machaliński, B. (2009) · Ophthalmic Research · doi:10.1159/000219686 · Cited by 60
A search for age-related macular degeneration risk variants in Alzheimer disease genes and pathways
Logue, M. W., Schu, M., Vardarajan, B. N., Farrell, J., Lunetta, K. L., Jun, G., Baldwin, C. T., DeAngelis, M. M., & Farrer, L. A. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.12.007 · Cited by 60
“HTRA1 (Edwards et al., 2005; Haines et al., 2005; Jakobsdottir et al., 2005; Klein et al., 2005; Rivera et al., 2005).”
Self-citationUnbiased Approaches to Biomarker Discovery in Neurodegenerative Diseases
Chen-Plotkin, A. S. (2014) · Neuron · doi:10.1016/j.neuron.2014.10.031 · Cited by 61
Hu, C.-C., Ho, J., & Lin, H. (2010) · Stroke · doi:10.1161/strokeaha.109.571000 · Cited by 69
Andreoli, M. T., Morrison, M. A., Kim, B. J., Chen, L., Adams, S. M., Miller, J. W., DeAngelis, M. M., & Kim, I. K. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.07.002 · Cited by 62
Iannaccone, A., Giorgianni, F., New, D. D., Hollingsworth, T., Umfress, A. C., Alhatem, A., Neeli, I., Lenchik, N. I., Jennings, B., Calzada, J. I., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145323 · Cited by 68
Progress in developing rodent models of age-related macular degeneration (AMD)
Pandi, S. P. S., Ratnayaka, J. A., Lotery, A. J., & Teeling, J. L. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.108404 · Cited by 66
Lorés‐Motta, L., van Beek, A. E., Willems, E., Zandstra, J., van Mierlo, G. J., Einhaus, A., Mary, J.-L., Stucki, C., Bakker, B., Hoyng, C. B., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.06.002 · Cited by 67
Dwyer, M. A., Kazmin, D., Hu, P., McDonnell, D. P., & Malek, G. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0392 · Cited by 61
Whitmore, S. S., Braun, T. A., Skeie, J. M., Haas, C. M., Sohn, E. H., Stone, E. M., Scheetz, T. E., & Mullins, R. F. (2013) · PubMed Central · Cited by 75
Of mice and men: The factor H protein family and complement regulation
Pouw, R. B., Vredevoogd, D. W., Kuijpers, T. W., & Wouters, D. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.03.011 · Cited by 68
Sparrow, J. R. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-5635-4_5 · Cited by 66
Analysis of the indel at the ARMS2 3′UTR in age-related macular degeneration
Wang, G., Spencer, K. L., Scott, W. K., Whitehead, P., Court, B. L., Ayala-Haedo, J., Mayo, P., Schwartz, S. G., Kovach, J. L., Gallins, P., et al. (2010) · Human Genetics · doi:10.1007/s00439-010-0805-8 · Cited by 61
“…Agarwal Department of Ophthalmology, Vanderbilt University, Nashville, TN 37232, USA E. A. Postel Duke Eye Center, Duke University Medical Center, Durham, NC 27710, USA (Haines et al. 2005; Hageman et al. 2005; Klein et al. 2005; Edwards et al. 2005; Zareparsi et al. 2005; Conley et al. 2005).”
Genetic associations in polypoidal choroidal vasculopathy: a systematic review and meta-analysis.
Chen, H., Liu, K., Chen, L. J., Hou, P., Chen, W., & Pang, C. P. (2012) · PubMed Central · doi:10.1501/0002208 · Cited by 66
Murine systemic thrombophilia and hemolytic uremic syndrome from a factor H point mutation
Ueda, Y., Mohammed, I., Song, D., Gullipalli, D., Zhou, L., Sato, S., Wang, Y., Gupta, S., Cheng, Z. A., Wang, H., et al. (2017) · Blood · doi:10.1182/blood-2016-07-728253 · Cited by 64
Ross, R. J., Zhou, M., Shen, D., Fariss, R. N., Ding, X., Bojanowski, C. M., Tuo, J., & Chan, C.-C. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.01.014 · Cited by 60
Despriet, D. D. G., Bergen, A. A. B., Merriam, J. E., Zernant, J., Barile, G. R., Smith, R. T., Barbazetto, I. A., van Soest, S., Bakker, A., de Jong, P. T. V. M., et al. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0656 · Cited by 60
Orlin, A., Hadley, D., Chang, W., Ho, A. C., Brown, G., Kaiser, R. S., Regillo, C. D., Godshalk, A. N., Lier, A., Kaderli, B., et al. (2012) · Retina · doi:10.1097/iae.0b013e31822a2c7c · Cited by 60
Drugs in Phase II clinical trials for the treatment of age-related macular degeneration
Tolentino, M. J., Dennrick, A., John, E., & Tolentino, M. S. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.961601 · Cited by 58
“Polymorphisms in two major loci, the 1q32 (CFH, CFHR and F13B), which play a role in the complement system, and 10q26 (ARMS2, HTRA1 and PLEKHA1), which plays roles in oxidation, immunity and extracellular matrix (ECM) maintenance, have been associated with the development and progression of AMD [14-18].”
BackgroundGenome-Wide Association Study for Reproductive Traits in a Duroc Pig Population
Zhang, Z., Chen, Z., Ye, S., He, Y., Huang, S., Yuan, X., Chen, Z., Zhang, H., & Li, J. (2019) · Animals · doi:10.3390/ani9100732 · Cited by 60
“BICC1 has been identified by GWAS as a candidate gene associated with major depressive disorder in humans [20].”
BackgroundInfluentialTherapeutic targeting of the complement system in age‐related macular degeneration: a review
Troutbeck, R., Al‐Qureshi, S., & Guymer, R. H. (2012) · Clinical & Experimental Ophthalmology · doi:10.1111/j.1442-9071.2011.02581.x · Cited by 57
Rastogi, N., & Smith, R. T. (2015) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2015.10.003 · Cited by 63
Mecamylamine Suppresses Basal and Nicotine-Stimulated Choroidal Neovascularization
Kiuchi, K., Matsuoka, M., Wu, J., Silva, R. L. E., Kengatharan, M., Mary, V., Ueno, S., Yokoi, K., Khu, N. H., Cooke, J. P., et al. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0089 · Cited by 60
DNA analysis by mass spectrometry—past, present and future
Tost, J., & Gut, I. G. (2006) · Journal of Mass Spectrometry · doi:10.1002/jms.1096 · Cited by 68
Michaelides, M., Jenkins, S. A., Brantley, M. A., Andrews, R. M., Waseem, N. H., Luong, V., Gregory-Evans, K., Bhattacharya, S. S., Fitzke, F. W., & Webster, A. R. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-1600 · Cited by 61
Radeke, M. J., Peterson, K. E., Johnson, L. V., & Anderson, D. H. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2007.05.006 · Cited by 64
Monaghan-Benson, E., Hartmann, J., Vendrov, A. E., Budd, S., Byfield, G. E., Parker, A., Ahmad, F. I., Huang, W. C., Runge, M. S., Burridge, K., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090878 · Cited by 61
“The current thinking is that a genetic predisposition accompanied by exogenous, chronic, repeated stresses could lead to tissue damage and dysfunction that becomes apparent only later in life.(10,12,13) In support of this theory is clinical evidence of independent and sometimes additive risk of advanced AMD from envir…”
BackgroundSupport for the involvement of complement factor I in age-related macular degeneration
Ennis, S., Gibson, J., Cree, A. J., Collins, A. R., & Lotery, A. J. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.113 · Cited by 65
Klein, R., Myers, C. E., Meuer, S. M., Gangnon, R. E., Sivakumaran, T. A., Iyengar, S. K., Lee, K. E., & Klein, B. E. K. (2012) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.713 · Cited by 65
“F OLLOWING THE OBSERVAtions of the associations of specific single-nucleotide polymorphisms (SNPs) in the complement factor H region (CFH, rs1061170) and in the age-related maculopathy susceptibility 2 region (ARMS2, rs10490924) with late agerelated macular degeneration (AMD), there has been a growing number of studie…”
Complement cascade functions during brain development and neurodegeneration
Fatoba, O., Itokazu, T., & Yamashita, T. (2021) · FEBS Journal · doi:10.1111/febs.15772 · Cited by 61
Gorman, B. R., Voloudakis, G., Igo, R. P., Kinzy, T. G., Halladay, C. W., Bigdeli, T. B., Zeng, B., Venkatesh, S., Bailey, J. N. C., Crawford, D. C., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01764-0 · Cited by 68
Self-citationFundus autofluorescence in exudative age-related macular degeneration
McBain, V. A., Townend, J., & Lois, N. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.095109 · Cited by 65
Complement dysregulation in AMD: RPE-Bruch’s membrane-choroid
Sparrow, J. R., Ueda, K., & Zhou, J. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.03.007 · Cited by 57
“The question remains as to whether the Y402H polymorphism is a causal site or whether because of linkage disequilibrium, it serves as a marker of another causal variant (Sofat et al., 2012).”
BackgroundInfluentialBandyopadhyay, M., & Rohrer, B. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-8638 · Cited by 53
McKay, G. J., Silvestri, G., Patterson, C. C., Hogg, R. E., Chakravarthy, U., & Hughes, A. E. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2275 · Cited by 59
Fujimoto, T. R., Sonoda, K., Hijioka, K., Sato, K., Takeda, A., Hasegawa, E., Oshima, Y., & Ishibashi, T. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4464 · Cited by 61
Wu, W., Hu, D., Gao, H.-X., Chen, M., Wang, D., Rosen, R. B., & McCormick, S. A. (2010) · PubMed Central · Cited by 75
Dietary modification and supplementation for the treatment of age-related macular degeneration
Broadhead, G., Grigg, J., Chang, A., & McCluskey, P. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuv005 · Cited by 66
Complement Factor H 402H Variant and Reticular Macular Disease
Smith, R. T., Merriam, J. E., Sohrab, M. A., Pumariega, N. M., Barile, G., Blonska, A. M., Haans, R., Madigan, D., & Allikmets, R. (2011) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2011.212 · Cited by 60
Monomeric C‐reactive protein and inflammation in age‐related macular degeneration
Chirco, K. R., Whitmore, S. S., Wang, K., Potempa, L. A., Halder, J. A., Stone, E. M., Tucker, B. A., & Mullins, R. F. (2016) · The Journal of Pathology · doi:10.1002/path.4766 · Cited by 58
Human HtrA1 in the archived eyes with age-related macular degeneration.
Chan, C., Shen, D., Zhou, M., Ross, R. J., Ding, X., Zhang, K., Green, W. R., & Tuo, J. (2007) · Europe PMC (PubMed Central) · Cited by 68
Was the Human Genome Project Worth the Effort?
Daiger, S. P. (2005) · Science · doi:10.1126/science.1111655 · Cited by 59
Evidence for association between multiple complement pathway genes and AMD
Dinu, V., Miller, P. L., & Zhao, H. (2007) · Genetic Epidemiology · doi:10.1002/gepi.20204 · Cited by 58
“Recent evidence points to the strong association of a complement factor H (CFH) variant, Y402H, with AMD [Edwards et al., 2005; Haines et al., 2005; Klein et al., 2005].”
BackgroundWang, L., Cano, M., Datta, S., Wei, H., Ebrahimi, K. B., Gorashi, Y., Garlanda, C., & Handa, J. T. (2016) · The Journal of Pathology · doi:10.1002/path.4811 · Cited by 61
Chirco, K. R., & Potempa, L. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00539 · Cited by 58
Genetics of age-related macular degeneration
Ting, A., Lee, T. K. M., & MacDonald, I. M. (2009) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e32832f8016 · Cited by 65
Wooten, E. C., Iyer, L. K., Montefusco, M. C., Kelley-Hedgepeth, A., Payne, D. D., Kapur, N. K., Housman, D. E., Mendelsohn, M. E., & Huggins, G. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008830 · Cited by 63
“have also proven particularly effective in identifying diseaserelated genes for highly heritable disorders such as age-dependent macular degeneration [12].”
BackgroundGenetic Factors for Choroidal Neovascularization Associated with High Myopia
Leveziel, N., Yu, Y., Reynolds, R. C., Tai, A., Meng, W., Caillaux, V., Calvas, P., ROSNER, B. A., Malecaze, F., Souied, E. H., et al. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-9538 · Cited by 65
Kondo, N., Bessho, H., Honda, S., & Negi, A. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.06.040 · Cited by 58
Hageman, G. S., Gehrs, K., Lejnine, S., Bansal, A. T., DeAngelis, M. M., Guymer, R. H., Baird, P. N., Allikmets, R., Deciu, C., Oeth, P., et al. (2011) · Human Genomics · doi:10.1186/1479-7364-5-5-420 · Cited by 57
Late-onset retinal macular degeneration: clinical insights into an inherited retinal degeneration
Borooah, S., Collins, C. E., Wright, A. F., & Dhillon, B. (2008) · Postgraduate Medical Journal · doi:10.1136/bjo.2008.150151 · Cited by 62
Grunin, M. A., Burstyn‐Cohen, T., Hagbi-Levi, S., Peled, A., & Chowers, I. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-9165 · Cited by 62
Borras, C., Canonica, J., Jorieux, S., Abache, T., El Sanharawi, M., Klein, C., Delaunay, K., Jonet, L., Salvodelli, M., Naud, M.-C., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50420-9 · Cited by 59
Hallam, T. M., Marchbank, K. J., Harris, C. L., Osmond, C., Shuttleworth, V. G., Griffiths, H., Cree, A. J., Kavanagh, D., & Lotery, A. J. (2020) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.61.6.18 · Cited by 57
Tsuchihashi, T., Mori, K., Horie‐Inoue, K., Gehlbach, P. L., Kabasawa, S., Takita, H., Ueyama, K., Okazaki, Y., Inoue, S., Awata, T., et al. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.04.007 · Cited by 63
Stem cells as a therapeutic tool for the blind: biology and future prospects
Singh, M. S., & MacLaren, R. E. (2011) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2011.1028 · Cited by 62
COMPLEMENT INHIBITION FOR GEOGRAPHIC ATROPHY: Review of Salient Functional Outcomes and Perspective
Spaide, R. F., & Vavvas, D. G. (2023) · Retina · doi:10.1097/iae.0000000000003796 · Cited by 67
Schadt, E. E., Zhang, B., & Zhu, J. (2009) · Genetica · doi:10.1007/s10709-009-9359-x · Cited by 60
“…leading to an explosion of discoveries from genetic association studies in a diversity of disease areas, including age-related macular degeneration (Edwards et al. 2005; Haines et al. 2005; Klein et al. 2005), heart disease (Helgadottir et al. 2007; McPherson et al. 2007), host control of…”
BackgroundAltered Expression of CD46 and CD59 on Leukocytes in Neovascular Age-Related Macular Degeneration
Singh, A., Faber, C., Falk, M. K., Nissen, M. H., Hviid, T. V. F., & Sørensen, T. L. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2012.01.036 · Cited by 62
Age-related accumulation of 3-nitrotyrosine and nitro-A2E in human Bruch's membrane
Murdaugh, L. S., Wang, Z., Priore, L. V. D., Dillon, J. P., & Gaillard, E. R. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.01.014 · Cited by 60
Complement factor H and hemicentin-1 in age-related macular degeneration and renal phenotypes
Thompson, C. L., Klein, R., Klein, R., Xu, Z., Capriotti, J., Joshi, T., Leontiev, D. V., Lee, K. E., Elston, R. C., & Iyengar, S. K. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm164 · Cited by 60
The Proteomic Landscape in the Vitreous of Patients With Age-Related and Diabetic Retinal Disease
Schori, C., Trachsel, C., Grossmann, J., Zygoula, I., Barthelmes, D., & Grimm, C. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-24122 · Cited by 63
Zeng, S., Whitmore, S. S., Sohn, E. H., Riker, M. J., Wiley, L. A., Scheetz, T. E., Stone, E. M., Tucker, B. A., & Mullins, R. F. (2016) · The Journal of Pathology · doi:10.1002/path.4669 · Cited by 56
Synthesis and Propagation of Complement C3 by Microglia/Monocytes in the Aging Retina
Rutar, M., Valter, K., Natoli, R., & Provis, J. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093343 · Cited by 56
“These identified a significant association between the Y402H sequence variant in the regulatory gene complement factor H (CFH) with the incidence of AMD [16,17,18,19], along with other susceptibility variants in complement pathway genes C2 [12,20], CFB [12,20], and the central component C3 [21,22,23,24,25] in”
BackgroundRomero‐Vázquez, S., Llorens, V., Soler-Boronat, A., Figueras‐Roca, M., Adán, A., & Molins, B. (2021) · Biomedicines · doi:10.3390/biomedicines9070763 · Cited by 62
Bayesian variable and model selection methods for genetic association studies
Fridley, B. L. (2008) · Genetic Epidemiology · doi:10.1002/gepi.20353 · Cited by 69
“SNPs across TLR3 and TLR7 were genotyped in two clinic-based cohorts consisting of 396 cases with AMD and 181 examined controls without AMD [Edwards et al., 2005].”
InfluentialKenney, M. C., Hertzog, D., Chak, G., Atilano, S. R., Khatibi, N., Soe, K., Nobe, A., Yang, E., Chwa, M., Zhu, F., et al. (2013) · BMC Medical Genetics · doi:10.1186/1471-2350-14-4 · Cited by 54
“The CFH gene polymorphism (rs1061170), T1277C (Tyr402His) has been associated with the development and progression of AMD [25-29] in Caucasian populations but not Asians [30-32].”
BackgroundProteomic Landscape of the Human Choroid–Retinal Pigment Epithelial Complex
Skeie, J. M., & Mahajan, V. B. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2014.2065 · Cited by 56
Age‐Related Macular Degeneration: Linking Clinical Presentation to Pathology
Nivison‐Smith, L., Milston, R., Madigan, M. C., & Kalloniatis, M. (2014) · Optometry and Vision Science · doi:10.1097/opx.0000000000000281 · Cited by 61
“However, this process must be integral to drusen formation as many genetic variants associated with AMD are genes that code for complement or complement-related proteins, such as complement factor H.(44) Environmental risk factors associated with AMD, such as smoking, are also implicated in the activation of complemen…”
BackgroundGenomewide Association, Parkinson Disease, and PARK10
Farrer, M. J., Haugarvoll, K., Ross, O. A., Stone, J. T., Milkovic, N. M., Cobb, S. A., Whittle, A. J., Lincoln, S., Hulihan, M., Heckman, M. G., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/504728 · Cited by 56
Are We Ready for Genome-wide Association Studies?
Thomas, D. C. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0146 · Cited by 61
“Time will tell whether these early reports represent true positives, but the simultaneous publication in Science of two confirmatory studies (11, 12) for the Complement Factor H association with age-related macular degeneration along with the GWA scan has sparked great enthusiasm, and several reports have seemed subse…”
ResultComplement regulation in the eye: implications for age-related macular degeneration
Wilke, G. A., & Apte, R. S. (2024) · Journal of Clinical Investigation · doi:10.1172/jci178296 · Cited by 55
Age-Related Macular Degeneration Preferred Practice Pattern®
Vemulakonda, G. A., Bailey, S. T., Kim, S. J., Kovach, J. L., Lim, J. I., Ying, G., & Flaxel, C. J. (2025) · Ophthalmology · doi:10.1016/j.ophtha.2024.12.018 · Cited by 64
Nan, R., Gor, J., Lengyel, I., & Perkins, S. J. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.10.030 · Cited by 64
Expression of Complement Component 3 (C3) from an Adenovirus Leads to Pathology in the Murine Retina
Cashman, S. M., Desai, A., Ramo, K., & Kumar-Singh, R. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6002 · Cited by 51
Polymorphisms in the VEGFA and VEGFR-2 genes and neovascular age-related macular degeneration.
Fang, A., Lee, A., Kulkarni, M., Osborn, M. P., & Brantley, M. A. (2009) · PubMed · Cited by 61
(2011) · Europe PMC (PubMed Central) · Cited by 55
The Role of the Complement System in Age-Related Macular Degeneration
Weber, B. H. F., Issa, P. C., Pauly, D., Herrmann, P., Graßmann, F., & Holz, F. G. (2014) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2014.0133 · Cited by 65
Not All Stressors Are Equal: Mechanism of Stressors on RPE Cell Degeneration
Tong, Y., & Wang, S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.591067 · Cited by 60
“Usually, intracellular ATP levels remain unchanged during the whole apoptotic process while ATP depletion happens in necrosis (Eguchi et al., 1997).”
BackgroundThe simple design of complement factor H: Looks can be deceiving
Alexander, J. J., & Quigg, R. J. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.07.287 · Cited by 58
“…when four groups of investigators independently howed genetic linkage of CFH with AMD (Klein et al., 2005; aines et al., 2005; Hageman et al., 2005; Edwards et al., 2005). ubsequent work has identified this allotypic variation to be ttributable to a His384Tyr polymorphism; this is in a polyanon…”
Background
Metadata
- Authors
- Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A.
- Affiliations
- Boston University (US)
- Corresponding author
- Edwards, Albert O.
- Venue
- Science
- Published
- 2005-04-15
- Volume
- 308
- Issue
- 5720
- Pages
- 421-424
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W3145351529
- Cited by
- 2,449
- References
- 30
- Citations by year
- 2026: 24 · 2025: 41 · 2024: 51 · 2023: 48 · 2022: 78 · 2021: 105 · 2020: 73 · 2019: 52 · 2018: 81 · 2017: 65 · 2016: 89 · 2015: 120 · 2014: 141 · 2013: 146 · 2012: 166
- FWCI
- 195.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Eye Institute (EY014467, R01EY014467)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- age-related macular degeneration, complement factor H, CFH Y402H polymorphism, single nucleotide polymorphisms, genetic association, disease risk
- MeSH terms
- Aged, Alleles, Chromosomes, Human, Pair 1, Complement Activation, Female, Gene Frequency, Multigene Family, Genotype, Haplotypes, Histidine, Homozygote, Humans, Macular Degeneration, Male, Middle Aged, Risk Factors, Tyrosine, Genetic Variation, Linkage Disequilibrium, Case-Control Studies, Complement Factor H, Amino Acid Substitution, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.